Clinical Trial Update: A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Pediatric Participants With Moderate to Severe Plaque Psoriasis [Phase 3]

View source ↗

Summary

Phase 3 pediatric trial to evaluate the drug levels, efficacy, and safety of deucravacitinib in children with moderate-to-severe plaque psoriasis; recruitment i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Deucravacitinib (deucravacitinib)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Plaque Psoriasis | Phase 3 | Status: RECRUITING